PubRank

Naoya Yamazaki

Author PubWeight™ 26.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update. Int J Clin Oncol 2008 1.63
2 Self-involution of giant keratoacanthoma on the tip of the nose. Plast Reconstr Surg 2003 1.37
3 Metastatic angiosarcoma of the lung: spectrum of CT findings. AJR Am J Roentgenol 2003 1.26
4 Mutant IDH1 confers an in vivo growth in a melanoma cell line with BRAF mutation. Am J Pathol 2011 1.26
5 Dendritic cell-based vaccination in metastatic melanoma patients: phase II clinical trial. Oncol Rep 2012 1.05
6 Identification of melanoma antigens using a Serological Proteome Approach (SERPA). Cancer Genomics Proteomics 2010 0.99
7 Postmarketing surveillance study of erlotinib in Japanese patients with non-small-cell lung cancer (NSCLC): an interim analysis of 3488 patients (POLARSTAR). J Thorac Oncol 2012 0.99
8 Efficacy of taxane regimens in patients with metastatic angiosarcoma. Eur J Dermatol 2011 0.94
9 Applicability of radiocolloids, blue dyes and fluorescent indocyanine green to sentinel node biopsy in melanoma. J Dermatol 2011 0.92
10 Erlotinib-related skin toxicities: treatment strategies in patients with metastatic non-small cell lung cancer. J Am Acad Dermatol 2013 0.90
11 Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells. J Transl Med 2005 0.89
12 Cytokeratin 7 staining was useful in a case of pigmented mammary Paget's disease resembling malignant melanoma. Int J Dermatol 2006 0.89
13 Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients. Cancer 2005 0.88
14 Sentinel lymph node biopsy guided by indocyanine green fluorescence for cutaneous melanoma. Eur J Dermatol 2011 0.87
15 Panitumumab in Japanese patients with unresectable colorectal cancer: a post-marketing surveillance study of 3085 patients. Jpn J Clin Oncol 2014 0.87
16 Metastatic melanoma on the abdominal wall. Jpn J Clin Oncol 2009 0.86
17 Cytotoxic T cell induction against human malignant melanoma cells using HLA-A24-restricted melanoma peptide cocktail. Anticancer Res 2004 0.85
18 Syringoid eccrine carcinoma with apparently aggressive transformation: case report and review of the literature. Int J Dermatol 2006 0.85
19 Limitation of indocyanine green fluorescence in identifying sentinel lymph node prior to skin incision in cutaneous melanoma. Int J Clin Oncol 2013 0.84
20 Phase I and pharmacokinetic/pharmacodynamic study of RO5126766, a first-in-class dual Raf/MEK inhibitor, in Japanese patients with advanced solid tumors. Cancer Chemother Pharmacol 2013 0.84
21 Prediction of additional lymph node positivity and clinical outcome of micrometastases in sentinel lymph nodes in cutaneous melanoma: a multi-institutional study of 450 patients in Japan. J Dermatol 2011 0.83
22 Contrasting prognostic implications of platelet-derived growth factor receptor-β and vascular endothelial growth factor receptor-2 in patients with angiosarcoma. Ann Surg Oncol 2011 0.82
23 Final safety and efficacy of erlotinib in the phase 4 POLARSTAR surveillance study of 10 708 Japanese patients with non-small-cell lung cancer. Cancer Sci 2014 0.81
24 Identification of cytomegalovirus (CMV)pp65 antigen-specific human monoclonal antibodies using single B cell-based antibody gene cloning from melanoma patients. Immunol Lett 2010 0.79
25 Clinicopathological significance of sentinel node biopsy in Japanese patients with cutaneous malignant melanoma. J Dermatol 2010 0.78
26 MR imaging of hepatic metastasis in patients with malignant melanoma: evaluation of suspected lesions screened at contrast-enhanced CT. Eur J Radiol 2011 0.77
27 Characterization of a MAGE-1-derived HLA-A24 epitope-specific CTL line from a Japanese metastatic melanoma patient. Anticancer Res 2009 0.77
28 Novel approach to the characterization of melanoma associated-peptide-specific CTL lines from Japanese metastatic melanoma patients. Int J Oncol 2008 0.77
29 Case of advanced melanoma who died from meningitis carcinomatosa after carboplatin and paclitaxel with good response. J Dermatol 2014 0.76
30 [Keypoints in placing an intratracheal stent]. Kyobu Geka 2010 0.75
31 [Musculoskeletal tumors. II. Therapeutic strategy for vascular sarcoma--with special reference to the recent progress in chemotherapy]. Gan To Kagaku Ryoho 2010 0.75
32 A double-blind, placebo-controlled study of the safety and efficacy of vitamin K1 ointment for the treatment of patients with cetuximab-induced acneiform eruption. Jpn J Clin Oncol 2012 0.75
33 A case of sentinel node metastasis of superficial spreading melanoma with two lymphatic channels. Jpn J Clin Oncol 2008 0.75
34 Characterization of cytomegalovirus pp65-HLA-A24 peptide-specific CTL lines from metastatic melanoma patients. Oncol Rep 2009 0.75
35 Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumors. Invest New Drugs 2015 0.75
36 Sentinel lymph node mapping of melanoma using technetium-99m phytate by a hybrid single-photon emission computed tomography/computed tomography. J Dermatol 2014 0.75
37 A case of scalp angiosarcoma with lung metastases presenting as multiple thin-walled cysts. Jpn J Clin Oncol 2013 0.75